Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin vs. Gabapentin on Reducing Opioid Usage in Trauma Patients
NCT04705480Phase 4Completed
- Sponsor
- CAMC Health System
- Start
- Apr 2021
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in pain comparing Pregabalin, Gabapentin and Neither Pregabalin nor Gabapentin (3 arms). Primary endpoint: Reduction in Opioid Usage at 7 days. Started Apr 2021; status: completed.
02
Drugs
pregabalingabapentin
03
Conditions
pain
Beyond the preview
Go deeper on NCT04705480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04705480.